{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T19:58:14Z","timestamp":1769198294691,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2002,5,22]],"date-time":"2002-05-22T00:00:00Z","timestamp":1022025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,5,22]],"date-time":"2002-05-22T00:00:00Z","timestamp":1022025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2002,6,1]]},"DOI":"10.1038\/sj.gt.3301758","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T16:59:33Z","timestamp":1031158773000},"page":"749-751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides"],"prefix":"10.1038","volume":"9","author":[{"given":"M","family":"Magnani","sequence":"first","affiliation":[]},{"given":"L","family":"Rossi","sequence":"additional","affiliation":[]},{"given":"A","family":"Fraternale","sequence":"additional","affiliation":[]},{"given":"M","family":"Bianchi","sequence":"additional","affiliation":[]},{"given":"A","family":"Antonelli","sequence":"additional","affiliation":[]},{"given":"R","family":"Crinelli","sequence":"additional","affiliation":[]},{"given":"L","family":"Chiarantini","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2002,5,22]]},"reference":[{"key":"BF3301758_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1359-6446(00)01634-2","volume":"6","author":"SA Barker","year":"2001","unstructured":"Barker SA, Khossravi D . Drug delivery strategies for the new millenium Drug Discov Today 2001 6: 75\u201377","journal-title":"Drug Discov Today"},{"key":"BF3301758_CR2","first-page":"497","volume":"3","author":"TR Flott","year":"2001","unstructured":"Flott TR . Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy Curr Opin Mol Ther 2001 3: 497\u2013502","journal-title":"Curr Opin Mol Ther"},{"key":"BF3301758_CR3","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/sj.gt.3301551","volume":"8","author":"FD Cui","year":"2001","unstructured":"Cui FD et al. Highly efficient gene transfer into murine liver achieved by intravenous administraton of naked Epstein\u2013Barr virus (EBV)-based plasmid vectors Gene Therapy 2001 8: 1508\u20131513","journal-title":"Gene Therapy"},{"key":"BF3301758_CR4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/sj.gt.3301481","volume":"8","author":"GC Jayan","year":"2001","unstructured":"Jayan GC et al. SV-40-derived vectors provide effective transgene expression and inhbition HIV-using constitutive, conditional, and pol III promotors Gene Therapy 2001 8: 1033\u20131042","journal-title":"Gene Therapy"},{"key":"BF3301758_CR5","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1006\/mthe.2001.0344","volume":"3","author":"E Klimatcheva","year":"2001","unstructured":"Klimatcheva E et al. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibitor replication Mol Ther 2001 3: 928\u2013939","journal-title":"Mol Ther"},{"key":"BF3301758_CR6","first-page":"162","volume":"2","author":"JJ Schwartz","year":"2000","unstructured":"Schwartz JJ, Zhang S . Peptide-mediated cellular delivery Curr Opin Mol Ther 2000 2: 162\u2013167","journal-title":"Curr Opin Mol Ther"},{"key":"BF3301758_CR7","first-page":"297","volume":"2","author":"RL Juliano","year":"2000","unstructured":"Juliano RL, Yoo H . Aspects of the transport and delivery of antisense oligonucleotides Curr Opin Mol Ther 2000 2: 297\u2013303","journal-title":"Curr Opin Mol Ther"},{"key":"BF3301758_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v18.i1.10","volume":"18","author":"SP Vyas","year":"2001","unstructured":"Vyas SP, Singh A, Sihorkar V . Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting Crit Rev Ther Drug Carrier Syst 2001 18: 1\u201376","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"BF3301758_CR9","first-page":"557","volume":"15","author":"GJ Russell-Jones","year":"1998","unstructured":"Russell-Jones GJ . Use of vitamin B12 conjugates to deliver protein drugs by the oral route Crit Rev Ther Drug Carrier Sys 1998 15: 557\u2013586","journal-title":"Crit Rev Ther Drug Carrier Sys"},{"key":"BF3301758_CR10","first-page":"587","volume":"15","author":"JA Reddy","year":"1998","unstructured":"Reddy JA, Low PS . Folate-mediated targeting of theraputic and imaging agents to cancer Crit Rev Ther Drug Carrier Sys 1998 15: 587\u2013627","journal-title":"Crit Rev Ther Drug Carrier Sys"},{"key":"BF3301758_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/86707","volume":"19","author":"A Becker","year":"2001","unstructured":"Becker A et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands Nature Biotech 2001 19: 327\u2013331","journal-title":"Nature Biotech"},{"key":"BF3301758_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1470-8744.1998.tb00505.x","volume":"28","author":"M Magnani","year":"1998","unstructured":"Magnani M et al. Erythrocyte engineering for drug delivery and targeting Biotechnol Appl Biochem 1998 28: 1\u20136","journal-title":"Biotechnol Appl Biochem"},{"key":"BF3301758_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1042\/BA20000087","volume":"33","author":"L Rossi","year":"2001","unstructured":"Rossi L et al. Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease Biotech Appl Biochem 2001 33: 85\u201389","journal-title":"Biotech Appl Biochem"},{"key":"BF3301758_CR14","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1073\/pnas.89.14.6477","volume":"89","author":"M Magnani","year":"1992","unstructured":"Magnani M et al. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies Proc Natl Acad Sci USA 1992 89: 6477\u20136481","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301758_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF00926740","volume":"144","author":"L Chiarantini","year":"1995","unstructured":"Chiarantini L, Rossi L, Fraternale A, Magnani M . Modulated red blood cell survival by membrane protein clustering Mol Cell Biochem 1995 144: 53\u201359","journal-title":"Mol Cell Biochem"},{"key":"BF3301758_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0166-3542(00)00101-7","volume":"47","author":"P Franchetti","year":"2000","unstructured":"Franchetti P et al. A new acyclic heterodinucleotide active against human immunodeficienct virus and herpes simplex virus Antivir Res 2000 47: 149\u2013158","journal-title":"Antivir Res"},{"key":"BF3301758_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/jac\/47.6.819","volume":"47","author":"L Rossi","year":"2001","unstructured":"Rossi L et al. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus J Antimicrob Chem 2001 47: 819\u2013827","journal-title":"J Antimicrob Chem"},{"key":"BF3301758_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jlb.62.1.133","volume":"62","author":"M Magnani","year":"1997","unstructured":"Magnani M et al. Targeting antiviral nucleotide analogues to macrophages J Leukocyte Biol 1997 62: 133\u2013137","journal-title":"J Leukocyte Biol"},{"key":"BF3301758_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1365-2141.1999.01202.x","volume":"104","author":"A Antonelli","year":"1999","unstructured":"Antonelli A et al. Efficient inhibition of macrophage TNF-\u03b1 production upon targeted delivery of K48R ubiquitin Br J Haematol 1999 104: 475\u2013481","journal-title":"Br J Haematol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301758.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301758","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301758.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T12:27:34Z","timestamp":1704284854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,22]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,6,1]]}},"alternative-id":["BF3301758"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301758","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5,22]]},"assertion":[{"value":"22 May 2002","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}